ArrowArtboardCreated with Sketch.Title ChevronTitle ChevronIcon FacebookIcon LinkedinIcon Mail ContactPath LayerIcon MailPositive ArrowIcon Print

Japan aims to secure COVID-19 vaccine for whole population by June

Fast-track approval an option for Pfizer, AstraZeneca or Moderna jabs

TOKYO -- Japan looks to begin distribution of COVID-19 vaccines by the March end of the fiscal year as clinical trials on a number of candidates move forward.

A Japanese trial of U.S.-based Moderna's vaccine candidate is expected to begin soon. Japan's Takeda Pharmaceutical is responsible for handling the approval application here, as well as sales and distribution.

Sponsored Content

About Sponsored Content This content was commissioned by Nikkei's Global Business Bureau.

Nikkei Asian Review, now known as Nikkei Asia, will be the voice of the Asian Century.

Celebrate our next chapter
Free access for everyone - Sep. 30

Find out more